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Within the testis, Sertoli-cell is the primary target of pituitary FSH. Several growth factors
have been described to be produced specifically by Sertoli cells and modulate male germ
cell development through paracrine mechanisms. Some have been shown to act directly
on spermatogonia such as GDNF, which acts on self-renewal of spermatogonial stem cells
(SSCs) while inhibiting their differentiation; BMP4, which has both a proliferative and differ-
entiative effect on these cells, and KIT ligand (KL), which stimulates the KIT tyrosine-kinase
receptor expressed by differentiating spermatogonia (but not by SSCs). KL not only controls
the proliferative cycles of KIT-positive spermatogonia, but it also stimulates the expression
of genes that are specific of the early phases of meiosis, whereas the expression of typ-
ical spermatogonial markers is down-regulated. On the contrary, FGF9 acts as a meiotic
inhibiting substance both in fetal gonocytes and in post-natal spermatogonia through the
induction of the RNA-binding protein NANOS2. Vitamin A, which is metabolized to Retinoic
Acid in Sertoli cells, controls both SSCs differentiation through KIT induction and NANOS2
inhibition, and meiotic entry of differentiating spermatogonia through STRA8 upregulation.
Keywords: primordial germ cells, spermatogonial stem cells, spermatogenesis, meiosis, growth factors, paracrine
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BRIEF INTRODUCTION: PARACRINE CONTROL OF FETAL
MALE GERM CELL DEVELOPMENT
The control of the germ cell fate by paracrine factors secreted by
the surrounding somatic environment already starts in the fetal
life in the period of germ cell specification, independently from
the influence of the hypothalamic-pituitary axis. Bone Morpho-
genetic Protein 4 (BMP4) has been shown to induce primordial
germ cell (PGC) formation, to act as a PGC survival and local-
ization factor within the allantois (1) and as a mitogen in in vitro
cultured PGCs (2). During PGC specification in the extraembry-
onic mesoderm, SOX2 induction is required for the transcriptional
regulation of KIT expression in PGCs (3). KIT is a tyrosine-kinase
receptor, which is activated by KIT Ligand (KL), a growth fac-
tor expressed by the surrounding somatic environment. KL/KIT
interaction is essential in the fetal period both during the specifi-
cation of PGCs and for their proliferation and migration [(3–7),
and references therein]. KIT expression is then down-regulated
both in fetal oocytes undergoing meiosis and in gonocytes, which
stop to proliferate after germ cell sex determination. Sertoli cells
can prevent meiotic entry of gonocytes through the production
of paracrine factors acting as meiotic inhibiting substances. The
best characterized meiotic inhibiting substance produced by fetal
Sertoli cells is Fibroblast Growth factor 9 (FGF9). FGF9 is a
SRY/SOX9-dependent growth factor crucial for male sex differ-
entiation acting on the somatic compartment of the fetal testis
(8, 9). However, FGF9 also acts directly on male fetal gonocytes by
upregulating levels of the RNA-binding protein NANOS2 (10, 11).
NANOS2 prevents meiosis through the post-transcriptional reg-
ulation of key genes involved in the meiotic program (10, 12, 13).
Recently, it has been shown that the meiosis-preventing activity of
FGF9 in the fetal testis is mediated, at least in part, by NODAL, a
member of the TGF-β family, and its partner Cripto (14–16).
In the same period in which FGF9 is expressed during testis
determination, Sertoli cells produce an enzyme, CYP26B1, which
degrades Retinoic Acid (RA) of mesonephric origin, in order to
block Stimulated by Retinoic Acid 8 (STRA8) expression, and, as
a consequence, to prevent premature gonocyte entry into meiosis
(17–20). Although the identification of RA as the CYP26B1 sub-
strate in the fetal testis (required for STRA8 induction and meiosis
initiation in the fetal ovary) has been questioned (21), most of the
available data in the literature support the role of RA as a master
inducer of the mitotic-meiotic switch in germ cells (22). In line
with this evidence is the finding that RA treatment down-regulates
NANOS2 expression in fetal gonocytes (10).
PARACRINE CONTROL OF POST-NATAL MALE GERM CELL
DEVELOPMENT
Pituitary gonadotropins, FSH, and LH, were originally identi-
fied for their essential role in ovarian function, as the stimulator
of follicular activity and the inducer of follicular luteinization,
respectively (23). Later on, it became clear that the same hormones
play important roles also in testicular function, FSH being involved
in the induction of spermatogenesis at puberty, and LH being the
main inducer of androgen production (24). Spermatogenesis is a
highly ordered differentiative process that occurs under FSH and
androgen control. Sertoli cells, the only known targets for these
hormones in the seminiferous tubules, mediate hormone action
on spermatogenesis by controlling the germinal stem cell niche
and by creating a suitable environment for the complex develop-
mental events of germ cell proliferation and differentiation. Sertoli
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cells directly orchestrate these complex events through both mem-
brane intercellular communications and the production of growth
factors and cytokines that act directly on the germ cell compart-
ment. In the following paragraphs we will focus on the better
characterized Sertoli-cell controlled paracrine mechanisms act-
ing on the early stages of mammalian spermatogenesis, which are
schematically summarized in Figure 1.
MAINTENANCE OF THE GERM STEM CELL NICHE
Spermatogonial stem cells (SSCs) are the direct descendants of
fetal gonocytes. In the testis, SSCs are a subpopulation of undif-
ferentiated spermatogonia residing in the basal layer of the sem-
iniferous epithelium. Their mitotic expansion allows continuous
production of germ cells committed to differentiation. One of the
specific properties of SSCs and other undifferentiated spermato-
gonia that distinguishes them from differentiating spermatogonia
is the expression of the Glial cell line-derived neurotrophic fac-
tor (GDNF)-family receptor α1 (GFRα1) and the c-Ret receptor
tyrosine-kinase, which are both required for signaling in response
to the Sertoli-cell-derived GDNF (25–28). GDNF has been shown
to be essential for fate determination of SSCs, since in aging
males heterozygotes for GDNF deletion, testes appear devoided
of germ cells and show a phenotype similar to Sertoli-cell-only
syndrome (25). Furthermore, overexpression of GDNF in mouse
testes appeared to stimulate self-renewal of stem cells and block
spermatogonial differentiation, inducing a seminomatous phe-
notype (25, 27). GDNF-induced activation of AKT and MEK
signaling pathways in SSCs leads to increased generation of reac-
tive oxygen species (ROS) generated by NAPDH oxidase 1, and
apparently (contrary to their alleged detrimental role for sper-
matogenesis) ROS stimulate proliferation and self-renewal of SSCs
through the activation of p38 and JNK MAPKs (29). Thus, GDNF
is important for SSCs self-renewal, and, at the same time negatively
controls their differentiation. This notion has been recently chal-
lenged by the finding that GFRα1-positive chained spermatogonia
(A paired and A aligned) are more numerous than GFRα1-positive
FIGURE 1 | Sertoli-cell controlled paracrine mechanisms acting on the
early stages of mammalian spermatogenesis. Paracrine factors
secreted by Sertoli cells (whose membrane is represented by dashed
circles) are enclosed within solid line circles. Follicle stimulating hormone
(FSH) is enclosed within a solid line square. Endogenous factors
expressed by germ cells are represented by non-enclosed words. Blue
colors refer to paracrine and endogenous factors that promote
self-renewal of spermatogonial stem cells (SSCs) and inhibit
spermatogonial differentiation and/or meiotic entry. Red colors refer to
paracrine and endogenous factors that promote spermatogonial
differentiation. Purple colors refer to endogenous factors which promote
spermatogonial differentiation but at the same time inhibit meiotic entry.
Green colors refer to endogenous factors that drive entry into meiosis.
Lines delimited by small ellipsoids refer to the stage of expression of the
germ cell endogenous factors involved in either self-renewal of SSCs and
inhibition of differentiation (blue colors) or in differentiation (red colors) and
meiotic entry (green colors). The succession of the various types of germ
cells during the earliest stages of mouse spermatogenesis is represented
in the center of the image: As, a single spermatogonia; Apr, a paired
spermatogonia; Aal, a aligned spermatogonia; A1, A2, A3, A4, type A1–A4
spermatogonia; Int, intermediate spermatogonia; B, type B
spermatogonia; PL, pre-leptotene spermatocytes.
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A single spermatogonia, which are thought to represent the major
SSCs reservoir in the mouse testis (30). However, GDNF signal-
ing is essential to maintain NANOS2 expression in SSCs, and it
has been proposed that this RNA-binding protein, besides its well-
established role in preventing meiosis in fetal gonocytes, is also
important to prevent spermatogonial differentiation in the post-
natal testis (31). Overall, it is clear that GDNF mainly acts in
positively regulating the proliferation of SSCs and maintenance
of their undifferentiated state. Importantly, FSH and its second
messenger cyclic AMP (cAMP) have been reported to stimulate
GDNF expression in Sertoli cells (32, 33), which is instead down-
regulated by RA treatment (33). These evidences suggest that
that GDNF might be one of the paracrine factors that influences
SSCs proliferation and population size under the control of the
hypothalamic-pituitary axis.
CONTROL OF SPERMATOGONIAL DIFFERENTIATION
Undifferentiated SSCs (A single spermatogonia) have been
described as single cells that are able both to renew themselves
and to produce more differentiated A paired spermatogonia. The
A paired cells then divide into A aligned spermatogonia that
further differentiate into A1 spermatogonia (34). Appearance of
A1 (differentiating) spermatogonia coincides with regain of the
expression of KIT, encoding the receptor for KL (35–38). KIT
mediates proliferation, survival, and differentiation in type A
spermatogonia (33, 39–41). Upon KIT expression, spermatogo-
nia become sensitive to KL produced by Sertoli cells (39, 42) and
undergo a definite number of proliferative cycles, forming the A2-
A4, intermediate, and B spermatogonia, before entering meiosis.
The temporal appearance of KIT expression and of KL sensitivity
in mouse spermatogonia, between 4 and 7 days postpartum (dpp)
(33, 35, 36, 40), marks the switch from the A aligned spermatogo-
nia to the A1-B differentiating cell types. Indeed, KIT is universally
considered the most important marker that distinguishes differ-
entiating spermatogonia from their undifferentiated precursors,
including SSCs. Thus, paracrine factors in the testicular environ-
ment that stimulate KIT expression in mitotic germ cells play an
essential role for the start of spermatogenesis at puberty. One
of the paracrine signals involved in this event is BMP4, which
is produced by Sertoli cells very early in the post-natal life, and
whose expression is positively regulated by cAMP and RA (33,
43). Its receptor ALK3 and the SMAD5 transducer are expressed
in undifferentiated spermatogonia, and in vitro treatment of these
cells with BMP4 exerts both mitogenic and differentiative effects,
inducing [3H]thymidine incorporation and KIT expression both
at the RNA and protein levels (43). As a result of the latter event,
KIT-negative spermatogonia acquire sensitivity to KL (43). Since
SSCs are able to renew themselves and at the same time to progress
through differentiation (i.e., to the KIT-dependent stages of pro-
liferation), BMP4 could be one of the factors that regulates such
process. Alternatively, BMP4 could act on a subset of undifferen-
tiated spermatogonia that have lost SSC features, i.e., that have
entered the differentiative stage but are not yet KIT-positive. In
agreement with the first possibility, BMP4 addition, on the oppo-
site of GDNF, was shown to impair in vitro maintenance of mouse
primary SSCs (44). Moreover, more recently BMP4 was shown
to induce differentiation and KIT expression in a rat SSC cell
line (45). In the adult testis, BMP4 has been reported to be pro-
duced by spermatogonia, but not by Sertoli cells (46), suggesting
that it might work as a paracrine-autocrine factor modulating the
establishment of the cycle of the seminiferous epithelium.
Another well-established paracrine factor involved in sper-
matogonial differentiation is the Vitamin A derivative RA. Mice
kept on a diet deficient on vitamin A (VAD mice) or lacking vit-
amin A derivatives are sterile because the seminiferous tubules
contain only undifferentiated KIT-negative spermatogonia, indi-
cating a role of vitamin A in spermatogonia differentiation (38,
47). RA functions inside the nucleus recognizing two different
classes of retinoid receptors. Both classes (RARs and RXRs) consist
of three types of receptors, α, β, and γ, encoded by distinct genes
and transduce RA signal by binding directly to RA-responsive
elements. During post-natal development, each RAR is detected
predominantly in a specific cell type of the seminiferous epithe-
lium: RARα in Sertoli cells, RARβ in round spermatids and RARγ
in type A spermatogonia (48). RARα conditional ablation in Ser-
toli cells showed germ cell apoptosis and seminiferous epithelium
dysfunctions related to the disruption of Sertoli cells cyclical gene
expression, which preceded testis degeneration (49). It has been
reported that during the first, prepubertal, spermatogenic cycle
RALDH-dependent synthesis of RA by Sertoli cells is indispens-
able to initiate differentiation of A aligned into A1 spermatogonia,
and that this effect is mainly mediated by autocrine action of
RA through RARα in the somatic compartment (50). However,
RA (either the all-trans or the 9-cis Retinoic isomers) treatment
in vitro exerts a direct effect on the differentiation of mitotic germ
cell compartment by promoting KIT expression in undifferenti-
ated spermatogonia (33, 51). This effect has been confirmed in vivo
by the observation that targeted ablation of RARγ impairs the A
aligned to A 1 transition in the course of some of the seminif-
erous epithelium cycles (52). Altogether these data indicate that
RA favors spermatogonial differentiation through a direct action
on spermatogonia and an indirect action mediated by changes in
the expression pattern of paracrine factors such as KL, BMP4, and
GDNF secreted by Sertoli cells (33).
Due to its importance for promoting expansion of differen-
tiating spermatogonia, KIT expression in SSCs is subjected to a
very tight transcriptional control. Promyelocytic Leukemia Zinc
Finger (PLZF, also known as ZFP145, or ZBTB16) is a DNA
sequence-specific transcriptional repressor that can exert local and
long-range chromatin remodeling activity through the recruit-
ment of DNA histone deacetylases and through the action of
several nuclear corepressors (53). PLZF is specifically expressed
in SSCs, and male PLZF knock-out (KO) mice show progres-
sive spermatogonia depletion due to the deregulated expression
of genes controlling the switch between self-renewal and differen-
tiation (54–56). PLZF represses both endogenous KIT expression
and expression of a reporter gene under the control of KIT reg-
ulatory elements (57). A discrete sequence of the KIT promoter,
required for PLZF-mediated KIT transcriptional repression, was
demonstrated to be bound by PLZF in vitro and also in vivo, by
using chromatin immunoprecipitation (ChIP) of spermatogonia.
Moreover, a 3-bp mutation in this PLZF binding site abolishes the
responsiveness of the KIT promoter to PLZF repression In agree-
ment with these findings, a significant increase in KIT expression
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was found in the undifferentiated spermatogonia isolated from
PLZF KO mice (57). Thus, one mechanism by which PLZF main-
tains the pool of SSCs is through a direct repression of KIT
transcription, thus acting as a gatekeeper of spermatogonial dif-
ferentiation. RA was shown to trigger downregulation of PLZF in
SSCs (58), which might be part of the mechanisms which triggers
up-regulation of KIT during spermatogonial differentiation.
Positive regulators of KIT transcription in spermatogonia are
two b-Helix-Loop-Helix (HLH) transcription factors specifically
expressed in germ cells, SOHLH1 (Spermatogenesis and Oogen-
esis HLH1), and SOHLH2. Both SOHLHs have been involved in
the differentiation of spermatogonia and oocytes (59–64). In the
male, deletion of each transcription factor leads to the disappear-
ance of KIT-expressing spermatogonia in the prepuberal testis. An
expression study of SOHLH1 and SOHLH2 during fetal and post-
natal development showed a strong positive correlation between
KIT and the two transcription factors in post-natal spermatogo-
nia (65). SOHLH2 was found enriched mainly in undifferenti-
ated spermatogonia, whereas SOHLH1 expression was maximal
in KIT-dependent stages. Reporter gene expression driven by
sequences contained within the KIT promoter and first intron was
strongly up-regulated in transfection experiments overexpressing
either SOHLH1 or SOHLH2, and co-transfection of both factors
showed a cooperative effect (65). In vivo, co-immunoprecipitation
results evidenced that the two proteins interact and overexpression
of both factors increased endogenous KIT expression. Using ChIP
analysis, SOHLH1 was found to occupy discrete bHLH binding
site containing regions within the KIT promoter in spermato-
gonia chromatin (64, 65). Interestingly, expression of SOHLH1
was increased in post-natal mitotic germ cells by treatment with
All-trans RA (65), which might be another mechanisms through
which vitamin A derivatives triggers KIT up-regulation and sper-
matogonial differentiation. Using conditional gene targeting, it
has been shown that loss of the Doublesex-related transcription
factor DMRT1 in spermatogonia causes a precocious exit from
the spermatogonial program and entry into meiosis (66). Appar-
ently, DMRT1 acts in differentiating spermatogonia by restricting
RA responsiveness, directly repressing transcription of the meiotic
inducer STRA8, and activating transcription of SOHLH1, thereby
preventing meiosis and promoting spermatogonial development
(66). In agreement with the direct role played by SOHLH1 in regu-
lating KIT transcription (65), a drastic reduction of KIT expression
in spermatogonia was evident in testes from DMRT1 conditional
KO mice (66).
Retinoic acid can up-regulate KIT expression in spermatogonia
also at the post-transcriptional level, by interfering with the action
of two X-linked microRNAs, miR-221 and miR-222 (67). Since
miR-221/222 negatively regulate both KIT mRNA and KIT pro-
tein abundance in spermatogonia, impaired expression of these
microRNAs in mouse undifferentiated spermatogonia induces
transition from a KIT-negative to a KIT-positive state and loss
of stem cell capacity to regenerate spermatogenesis. Undifferenti-
ated spermatogonia overexpressing miR-221/222 were found to be
resistant to RA-induced transition to a KIT-positive state and inca-
pable of differentiation in vivo (67). Moreover, growth factors that
promote maintenance of undifferentiated spermatogonia, such as
GDNF, were found to up-regulate miR-221/222 expression. On
the contrary, exposure to RA down-regulates miR-221/222 abun-
dance (67). In conclusion, RA promotes progression of SSCs to
differentiating spermatogonia through different mechanisms, all
of which positively influence KIT expression: downregulation of
PLZF and of miR-221/222, and up-regulation of SOHLH1.
CONTROL OF SPERMATOGONIAL EXPANSION
KIT ligand/KIT interaction is essential during post-natal stages of
spermatogenesis for the expansion of the differentiating spermato-
gonia pool. KL, expressed by Sertoli cells, stimulates proliferation
of differentiating type A1-A4 spermatogonia both by inducing
their progression into the mitotic cell cycle and by reducing
their apoptotic rate. This effect is exerted by the activated KIT
tyrosine-kinase using as signal transducers both PI3K-AKT and
MEK-ERK1/2 (39, 40, 68). The role of KIT/KL in the mainte-
nance and proliferation of differentiating spermatogonia has been
highlighted by a mouse genetic model with a point mutation
of KIT that eliminates the PI3K docking site (Y719F) through
a single bp change (69, 70). While PGC specification and pro-
liferation in both sexes is not compromised during embryonic
development, KIT(Y719F)/KIT(Y719F) males are sterile due to
the lack of spermatogonia proliferation during the prepuberal
period and an arrest of spermatogenesis at the pre-meiotic stages.
The KIT/KL system is also an important mediator of the influ-
ence of hypothalamic-pituitary axis on the spermatogenic process.
Indeed, the expression of the mRNA for KL is induced by FSH
in prepuberal mouse Sertoli cells cultured in vitro, through an
increase in cAMP levels (39, 42). The cAMP-dependent increase
in KL expression in Sertoli cells is mainly due to direct activation
of transcription from proximal promoter elements within the KL
gene (71). Stage-dependent induction of KL mRNA expression by
FSH has also been observed in the adult rat testis (72), and the
maximal levels of KL mRNA induction are observed in stages of
the seminiferous epithelium which show the maximal sensitivity to
FSH stimulation, and in which type A spermatogonia are actively
dividing. Interestingly, the soluble and membrane forms of KL,
produced by alternative splicing, are differentially expressed dur-
ing testis development. Sertoli cells from prepuberal mice mainly
express the mRNA encoding for the transmembrane form, while
the mRNA encoding for the soluble form is expressed at higher lev-
els later, in coincidence with the beginning of the spermatogenic
process, and the two transcripts are expressed at equivalent levels in
the adult testis (39). Moreover, FSH and/or cAMP analogs, beside
increasing KL mRNA levels, also modify the splicing pattern of the
two isoforms in cultured mouse Sertoli cells in favor of the mRNA
encoding for the soluble form (39). In agreement with these obser-
vations is the finding that the highest levels of the transmembrane
form of KL are detected immunohistochemically in stages VII-
VIII of the mouse seminiferous epithelium (73), which are the less
sensitive to FSH stimulation in the adult testis (74). It has been
hypothesized that the transmembrane form of KL could be phys-
iologically relevant for the progression through the blood-testis
barrier of mitotic germ cells entering the first meiotic prophase at
stages VII-VIII (5). Moreover, even though at the onset of meiosis
KIT expression in male germ cells ceases at both the RNA and
protein levels (5), KL/KIT interaction, besides its well-established
role in the expansion of differentiating type A spermatogonia, is
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also important for entry into the meiotic program, i.e., the transi-
tion from type B spermatogonia to pre-leptotene spermatocytes,
as discussed in the next paragraph.
CONTROL OF ENTRY INTO MEIOSIS
Retinoic acid acts in a bimodal mode to promote the spermato-
genic process. Indeed, besides its important role in promoting
progression of SSCs to differentiating spermatogonia through acti-
vation of KIT expression, RA also promotes expression of the
meiotic inducer STRA8 in spermatogonia (33, 51). Besides RA
of Sertoli-cell origin, it has been reported that also RA synthe-
sized by pre-meiotic spermatocytes cell autonomously induces
meiotic initiation through controlling the RAR-dependent expres-
sion of STRA8 in the same cells (50). Targeted ablation of STRA8
revealed a crucial role for this gene in the initial stages of the mei-
otic process in post-natal male germ cells, either in the transition
from type B spermatogonia/pre-leptotene to leptotene spermato-
cytes (75), or in slightly later stages of the meiotic prophase, with
mutant leptotene spermatocytes undergoing a premature mitotic-
like chromosome condensation (76). The mechanisms through
which STRA8 regulates the initial stages of meiosis in both sexes
are currently unknown. However, the role played by STRA8 in
male meiosis appears to be different from that played in the induc-
tion of the meiotic process in the fetal ovary, in which STRA8
ablation leads to an arrest of pre-meiotic DNA synthesis in pre-
leptotene oocytes (18), whereas the last round of germ cell DNA
synthesis appears not be affected in STRA8-deficient pre-leptotene
spermatocytes (75, 76). RA was found to increase meiotic entry
of mouse KIT-positive differentiating spermatogonia in vitro, as
evaluated by both morphological and biochemical criteria (33).
Increased expression of STRA8 and of early meiotic markers, such
as DMC1, accompanied the morphological switch from spermato-
gonia to pre-leptotene and leptotene spermatocytes. RA treatment
also increased STRA8 expression in in vitro cultured KIT-negative
undifferentiated spermatogonia, which included SSCs, but this was
not followed by induction of meiotic entry, suggesting that sper-
matogonial competence to enter meiosis is acquired only during
the differentiative stages in which they undergo KIT-dependent
mitotic divisions (33). Transcriptome analysis of in vitro cultured
differentiating spermatogonia stimulated with recombinant KL
revealed a pattern of RNA expression compatible with the qual-
itative changes of the cell cycle that occur during the subsequent
cell divisions in type A and B spermatogonia, i.e., the progres-
sive lengthening of the S phase and the shortening of the G2/M
transition (41). Moreover, KL treatment was found to up-regulate
in differentiating spermatogonia the expression of early meiotic
genes, and to down-regulate at the same time typical spermatogo-
nial markers, suggesting an important role for KL/KIT interaction
in the transition from the mitotic to the meiotic cell cycle, and
also an active role in the induction of meiotic differentiation (41).
Indeed, morphological and biochemical analysis of in vitro cul-
tured spermatogonia treated with KL revealed an induction of
STRA8 and DMC1 expression and of meiotic entry, evaluated as
a dramatic increase in the number of pre-leptotene and leptotene
spermatocytes similar to the one induced by RA treatment (33).
The effect of RA and KL on meiotic entry did not appear to be
additive, implying that these factors converge on common signal
transduction pathways to exert this effect. Indeed, similarly to KL,
RA treatment induced KIT autophosphorylation, MEK-ERK1/2
and PI3K-AKT activation, and selective inhibitors of any of these
pathways inhibited the biochemical and morphological signs of
meiotic entry. Thus, together with genomic effects leading to
increased expression of KIT in spermatogonia and of KL in Sertoli
cells, RA also exerts rapid non-genomic effects in differentiating
spermatogonia and converge with KL on common KIT-dependent
signaling pathways for the induction of meiotic entry (33).
In order to ensure the homeostasis of the spermatogenic
process, paracrine mechanisms, and endogenous effectors which
negatively regulate spermatogonial differentiation and the onset
of the meiotic process in post-natal spermatogenesis must coexist
with positive inducers such as RA and KL. One of these paracrine
mechanisms is analogous to the one operating to prevent meio-
sis onset in the fetal testis, and involves FGF9 expression in the
somatic environment of the seminiferous epithelium and expres-
sion of the RNA-binding protein NANOS2 in pre-meiotic germ
cells. In the post-natal testis, NANOS2 was found to be specifically
expressed at both the RNA and protein level in KIT-negative undif-
ferentiated spermatogonia, but not in KIT-positive differentiating
spermatogonia, nor in meiotic or postmeiotic germ cells (10).
FGF9 stimulation of in vitro cultured differentiating spermato-
gonia resulted in a dramatic induction of NANOS2 expression
and inhibition of the morphological and biochemical signs of
entry into meiosis, without apparent effects on the expression of
STRA8, whereas RA treatment resulted in a deep inhibition in
the levels of NANOS2 expression in undifferentiated spermatogo-
nia, together with the previously described stimulation of STRA8
expression (10). Thus, together with playing an essential role in
preventing meiosis of gonocytes in the male fetal testis, FGF9 acts
as an inhibitor of meiotic differentiation through the upregulation
of NANOS2 also in post-natal male mitotic germ cells.
FUTURE PERSPECTIVES
Obviously there must be also a paracrine influence of germ cells on
Sertoli-cell production of factors involved in the local control of
spermatogenesis, but, up to now, little information is available in
the literature about these germ cell-generated signals. On the other
hand, Sertoli cells are clearly the only mediators of the influence
of the hypothalamic-pituitary axis on the spermatogenic process.
FSH drives both Sertoli-cell secretion of GDNF, on one side, and of
BMP4 and KL, on the other side. This actually fits with the double
role exerted by the pituitary hormones, as inducers of spermato-
genesis at puberty (through the local mediation of BMP4 and KL),
but at the same time as essential for its maintenance and quanti-
tative output (through GDNF stimulation of SSCs self-renewal).
The factors which locally control the balance between GDNF vs.
BMP4 and KL secretion by Sertoli cells in response to FSH might
be germ cell-generated signals, and they must be the object of
further studies.
Another puzzling observation is that FGF9 exerts opposite
effects in KIT-positive differentiating spermatogonia with respect
to those elicited by RA and KL signaling. Indeed, it is intrigu-
ing to notice that KL and FGF9 act on the same germ cell type
stimulating receptor tyrosine-kinase activities (and thus presum-
ably partially shared signal transduction pathways), yet they exert
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opposite effects (differentiation and promotion of meiosis vs. pre-
vention of meiotic entry). It will be very important to dissect
the differences in intracellular signaling elicited in differentiat-
ing spermatogonia by these two antagonistic growth factors and
the downstream cascade of events that lead to RA/KL-mediated
induction of meiotic entry and FGF9-mediated inhibition of the
same process. For instance, it will be interesting to characterize
the subtypes of FGF receptors expressed in spermatogonia, and to
investigate whether activation of NODAL signaling is involved in
FGF9 action in post-natal male germ cells as it has been reported
for male fetal gonocytes (14–16). Preliminary results from our
laboratory indicate that both FGF9 and KL stimulate transient
ERK1/2 activation in spermatogonia, but PI3K-dependent AKT
activation is elicited by KL, but not by FGF9 (V. Tassinari, P. Rossi,
and S. Dolci, unpublished results). This might be of particular
importance, in light of the notion that in the mouse testis, as men-
tioned previously, a point mutation of KIT that eliminates the
PI3K docking site cause a total block of the spermatogenic process
between 8 and 10 dpp (69, 70), coinciding with of the onset of
meiosis in the male germ cell line, and that PI3K inhibitors com-
pletely block induction of meiotic entry elicited in vitro by RA
and/or KL treatment of differentiating spermatogonia (33).
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